期刊
CLINICAL INFECTIOUS DISEASES
卷 52, 期 -, 页码 S231-S237出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciq047
关键词
-
资金
- Bristol-Myers Squibb, Positive Charge Initiative
- Bristol-Myers Squibb, Positive Charge
- Bristol-Myers Squibb
- MS
- GlaxoSmithKline
- Gilead
- Merck
- Tibotec
Women currently account for 27% of new human immunodeficiency virus (HIV) infections in the United States, the majority of which are acquired through heterosexual transmission. In the United States, black and Latino persons are disproportionately affected by the HIV epidemic, a disparity that is most dramatically present among HIV-infected women. Many of these women face significant discrimination as a result of race or ethnicity and sex, and they suffer disproportionately from poverty, low health literacy, and lack of access to high-quality HIV care. As a consequence, despite the availability of highly active antiretroviral therapy (HAART), women with HIV often have delayed entry into care and experience poor outcomes. This article reviews risk factors for HIV infection in women, barriers to engagement in care, and strategies to improve linkage to HIV-related medical and social care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据